Literature DB >> 33481912

The independent factors associated with oxygen therapy in COVID-19 patients under 65 years old.

Yue-Nan Ni1, Ting Wang1, Bin-Miao Liang1, Zong-An Liang1.   

Abstract

BACKGROUND: The number of hospitalized young coronavirus disease 2019 (COVID-19) patients has increased significantly. However, specific data about COVID-19 patients under 65 years old who are admitted to the hospital are scarce.
METHODS: The COVID-19 patients under 65 years old who were admitted to the hospital in Sichuan Province, Renmin Hospital of Wuhan University, and Wuhan Red Cross Hospital were included in this study. Demographic information, laboratory data and clinical treatment courses were extracted from electronic medical records. Risk factors associated with oxygen therapy were explored.
RESULTS: Eight hundred thirty-three COVID-19 patients under 65 years old were included. Of the included patients, 29.4% had one or more comorbidities. Oxygen therapy was required in 63.1% of these patients, and the mortality was 2.9% among the oxygen therapy patients. Fever (odds ratio [OR] 2.072, 95% confidence interval [CI] 1.312-3.271, p = 0.002), dyspnea (OR 2.522, 95% CI 1.213-5.243, p = 0.013), chest distress (OR 2.278, 95% CI 1.160-4.473, p = 0.017), elevated respiratory rate (OR 1.114, 95% CI 1.010-1.228, p = 0.031), and decreased albumin (OR 0.932, 95% CI 0.880-0.987, p = 0.016) and globulin levels (OR 0.929, 95% 0.881-0.980, p = 0.007) were independent factors related to oxygen therapy.
CONCLUSIONS: Oxygen therapy is highly required in COVID-19 patients under 65 years old who are admitted to the hospital, but the success rate is high. Respiratory failure-related symptoms, elevated respiratory rate, low albumin and globulin levels, and fever at admission are independent risk factors related to the requirement of oxygen.

Entities:  

Mesh:

Year:  2021        PMID: 33481912      PMCID: PMC7822310          DOI: 10.1371/journal.pone.0245690

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  35 in total

1.  Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.

Authors:  Chen Wang; Jianying Xu; Lan Yang; Yongjian Xu; Xiangyan Zhang; Chunxue Bai; Jian Kang; Pixin Ran; Huahao Shen; Fuqiang Wen; Kewu Huang; Wanzhen Yao; Tieying Sun; Guangliang Shan; Ting Yang; Yingxiang Lin; Sinan Wu; Jianguo Zhu; Ruiying Wang; Zhihong Shi; Jianping Zhao; Xianwei Ye; Yuanlin Song; Qiuyue Wang; Yumin Zhou; Liren Ding; Ting Yang; Yahong Chen; Yanfei Guo; Fei Xiao; Yong Lu; Xiaoxia Peng; Biao Zhang; Dan Xiao; Chung-Shiuan Chen; Zuomin Wang; Hong Zhang; Xiaoning Bu; Xiaolei Zhang; Li An; Shu Zhang; Zhixin Cao; Qingyuan Zhan; Yuanhua Yang; Bin Cao; Huaping Dai; Lirong Liang; Jiang He
Journal:  Lancet       Date:  2018-04-09       Impact factor: 79.321

Review 2.  Hepatic involvement in COVID-19 patients: Pathology, pathogenesis, and clinical implications.

Authors:  Yueying Li; Shu-Yuan Xiao
Journal:  J Med Virol       Date:  2020-05-13       Impact factor: 2.327

3.  Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in California.

Authors:  Laura C Myers; Stephen M Parodi; Gabriel J Escobar; Vincent X Liu
Journal:  JAMA       Date:  2020-06-02       Impact factor: 56.272

4.  Dynamic changes in routine blood parameters of a severe COVID-19 case.

Authors:  Guoguang Lu; Jing Wang
Journal:  Clin Chim Acta       Date:  2020-05-13       Impact factor: 3.786

Review 5.  Changes in Nutritional Status Impact Immune Cell Metabolism and Function.

Authors:  Yazan Alwarawrah; Kaitlin Kiernan; Nancie J MacIver
Journal:  Front Immunol       Date:  2018-05-16       Impact factor: 7.561

6.  COVID-19 infection: the perspectives on immune responses.

Authors:  Yufang Shi; Ying Wang; Changshun Shao; Jianan Huang; Jianhe Gan; Xiaoping Huang; Enrico Bucci; Mauro Piacentini; Giuseppe Ippolito; Gerry Melino
Journal:  Cell Death Differ       Date:  2020-03-23       Impact factor: 15.828

7.  Viral Shedding and Antibody Response in 37 Patients With Middle East Respiratory Syndrome Coronavirus Infection.

Authors:  Victor M Corman; Ali M Albarrak; Ali Senosi Omrani; Mohammed M Albarrak; Mohamed Elamin Farah; Malak Almasri; Doreen Muth; Andrea Sieberg; Benjamin Meyer; Abdullah M Assiri; Tabea Binger; Katja Steinhagen; Erik Lattwein; Jaffar Al-Tawfiq; Marcel A Müller; Christian Drosten; Ziad A Memish
Journal:  Clin Infect Dis       Date:  2015-11-12       Impact factor: 9.079

8.  Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019.

Authors:  Juanjuan Zhao; Quan Yuan; Haiyan Wang; Wei Liu; Xuejiao Liao; Yingying Su; Xin Wang; Jing Yuan; Tingdong Li; Jinxiu Li; Shen Qian; Congming Hong; Fuxiang Wang; Yingxia Liu; Zhaoqin Wang; Qing He; Zhiyong Li; Bin He; Tianying Zhang; Yang Fu; Shengxiang Ge; Lei Liu; Jun Zhang; Ningshao Xia; Zheng Zhang
Journal:  Clin Infect Dis       Date:  2020-11-19       Impact factor: 9.079

9.  Association Between Hypoxemia and Mortality in Patients With COVID-19.

Authors:  Jiang Xie; Naima Covassin; Zhengyang Fan; Prachi Singh; Wei Gao; Guangxi Li; Tomas Kara; Virend K Somers
Journal:  Mayo Clin Proc       Date:  2020-04-11       Impact factor: 7.616

10.  Clinical progression of patients with COVID-19 in Shanghai, China.

Authors:  Jun Chen; Tangkai Qi; Li Liu; Yun Ling; Zhiping Qian; Tao Li; Feng Li; Qingnian Xu; Yuyi Zhang; Shuibao Xu; Zhigang Song; Yigang Zeng; Yinzhong Shen; Yuxin Shi; Tongyu Zhu; Hongzhou Lu
Journal:  J Infect       Date:  2020-03-19       Impact factor: 6.072

View more
  3 in total

1.  Neurological Prognostic Factors in Hospitalized Patients with COVID-19.

Authors:  Leszek Drabik; Justyna Derbisz; Zaneta Chatys-Bogacka; Iwona Mazurkiewicz; Katarzyna Sawczynska; Tomasz Kesek; Jacek Czepiel; Pawel Wrona; Joanna Szaleniec; Malgorzata Wojcik-Bugajska; Aleksander Garlicki; Maciej Malecki; Ralph Jozefowicz; Agnieszka Slowik; Marcin Wnuk
Journal:  Brain Sci       Date:  2022-01-30

2.  Predicting the necessity of oxygen therapy in the early stage of COVID-19 using machine learning.

Authors:  Sara Saadatmand; Khodakaram Salimifard; Reza Mohammadi; Maryam Marzban; Ahmad Naghibzadeh-Tahami
Journal:  Med Biol Eng Comput       Date:  2022-02-11       Impact factor: 3.079

3.  Reliability of predictive models to support early decision making in the emergency department for patients with confirmed diagnosis of COVID-19: the Pescara Covid Hospital score.

Authors:  Ennio Polilli; Antonella Frattari; Jessica Elisabetta Esposito; Milena D'Amato; Giorgia Rapacchiale; Angela D'Intino; Alberto Albani; Giancarlo Di Iorio; Fabrizio Carinci; Giustino Parruti
Journal:  BMC Health Serv Res       Date:  2022-08-19       Impact factor: 2.908

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.